The research team of Prof. Haiyan Xie has developed a new gene immunotherapy strategy specific to “immune-cold” solid tumors

Journal of Chinese Pharmaceutical Sciences ›› 2026, Vol. 35 ›› Issue (2): 204-204.

The research team of Prof. Haiyan Xie has developed a new gene immunotherapy strategy specific to “immune-cold” solid tumors

State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University Health Science Center

State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University Health Science Center

Received:2026-01-10 Revised:2026-01-10 Accepted:2026-01-10 Online:2026-03-05 Published:2026-03-05

Abstract

Supporting:

State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University Health Science Center. The research team of Prof. Haiyan Xie has developed a new gene immunotherapy strategy specific to “immune-cold” solid tumors[J]. Journal of Chinese Pharmaceutical Sciences, 2026, 35(2): 204-204.

The research team of Prof. Haiyan Xie has developed a new gene immunotherapy strategy specific to “immune-cold” solid tumors

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 0

Recommended Articles

Metrics

Comments